SIGA Technologies Inc is involved in the business of development and commercialization of solutions for serious unmet medical needs and biothreats. Its main product is TPOXX. The company expects to derive its revenue from sale of TPOXX. Its products target orthopoxvirus infections including smallpox. The firm's manufacturing facilities are located in Corvallia, Oregon state.